Clinical outcomes of continuous flow left ventricular assist device therapy as bridge to transplant strategy in muscular dystrophy: a single-center study
ConclusionIn selected MD patients with end-stage HF, cf-LVAD therapy is a viable therapeutic option as bridge to heart transplant.
Source: General Thoracic and Cardiovascular Surgery - Category: Cardiovascular & Thoracic Surgery Source Type: research
More News: Accidents | Cardiology | Cardiovascular | Cardiovascular & Thoracic Surgery | Heart | Heart Failure | Heart Transplant | Japan Health | Muscular Dystrophy | Pulmonary Function Testing | Reflex Sympathetic Dystrophy | Respiratory Medicine | Study | Transplant Surgery | Transplants | Ventricular Tachycardia | Waiting Times